{"id":557751,"date":"2026-06-21T22:56:45","date_gmt":"2026-06-21T20:56:45","guid":{"rendered":"https:\/\/medizinonline.com\/?p=557751"},"modified":"2026-06-23T12:54:01","modified_gmt":"2026-06-23T10:54:01","slug":"lupadacitinib-pour-le-traitement-de-la-dermatite-atopique-la-securite-dans-le-contexte-clinique","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/lupadacitinib-pour-le-traitement-de-la-dermatite-atopique-la-securite-dans-le-contexte-clinique\/","title":{"rendered":"L\u2019upadacitinib pour le traitement de la dermatite atopique\u00a0: La s\u00e9curit\u00e9 dans le contexte clinique"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Les prof.&nbsp;Dr&nbsp;Christopher G. Bunick et PD&nbsp;Dr&nbsp;Dr&nbsp;m\u00e9d. Ahmad Jalili ont abord\u00e9, dans un \u00e9change virtuel, les aspects actuels concernant l\u2019utilisation des inhibiteurs des JAK dans le traitement de la dermatite atopique (DA). La discussion a principalement port\u00e9 sur la classification des mises en garde de s\u00e9curit\u00e9, les donn\u00e9es \u00e0 long terme sur l\u2019upadacitinib ainsi que leur importance dans la pratique clinique quotidienne. L\u2019article suivant r\u00e9sume les principales d\u00e9clarations de cet entretien d\u2019experts et les replace dans le contexte th\u00e9rapeutique actuel.<\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Flupadacitinib-pour-le-traitement-de-la-dermatite-atopique-la-securite-dans-le-contexte-clinique%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Les prof.&nbsp;Dr&nbsp;Christopher G. Bunick et PD&nbsp;Dr&nbsp;Dr&nbsp;m\u00e9d. Ahmad Jalili ont abord\u00e9, dans un \u00e9change virtuel, les aspects actuels concernant l\u2019utilisation des inhibiteurs des JAK dans le traitement de la dermatite atopique&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Flupadacitinib-pour-le-traitement-de-la-dermatite-atopique-la-securite-dans-le-contexte-clinique%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":17461,"featured_media":557754,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Contenu sponsoris\u00e9: Dermatite atopique","footnotes":""},"category":[11549,11349,11362],"tags":[],"powerkit_post_featured":[],"class_list":["post-557751","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-allergologie-et-immunologie-clinique","category-dermatologie-et-venerologie","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-05 13:54:40","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/557751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/17461"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=557751"}],"version-history":[{"count":3,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/557751\/revisions"}],"predecessor-version":[{"id":559762,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/557751\/revisions\/559762"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/557754"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=557751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=557751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=557751"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=557751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}